AU2230692A - Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof - Google Patents

Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof

Info

Publication number
AU2230692A
AU2230692A AU22306/92A AU2230692A AU2230692A AU 2230692 A AU2230692 A AU 2230692A AU 22306/92 A AU22306/92 A AU 22306/92A AU 2230692 A AU2230692 A AU 2230692A AU 2230692 A AU2230692 A AU 2230692A
Authority
AU
Australia
Prior art keywords
beta
water
pharmaceutical formulation
soluble salt
clavulanic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU22306/92A
Other languages
English (en)
Inventor
David Clapham
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2230692A publication Critical patent/AU2230692A/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A61K31/429—Thiazoles condensed with heterocyclic ring systems
    • A61K31/43—Compounds containing 4-thia-1-azabicyclo [3.2.0] heptane ring systems, i.e. compounds containing a ring system of the formula, e.g. penicillins, penems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
AU22306/92A 1991-07-11 1992-07-03 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof Abandoned AU2230692A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB919114950A GB9114950D0 (en) 1991-07-11 1991-07-11 Pharmaceutical formulation
GB9114950 1991-07-11

Publications (1)

Publication Number Publication Date
AU2230692A true AU2230692A (en) 1993-02-11

Family

ID=10698173

Family Applications (1)

Application Number Title Priority Date Filing Date
AU22306/92A Abandoned AU2230692A (en) 1991-07-11 1992-07-03 Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof

Country Status (5)

Country Link
EP (1) EP0593573A1 (fr)
JP (1) JPH06508844A (fr)
AU (1) AU2230692A (fr)
GB (1) GB9114950D0 (fr)
WO (1) WO1993000898A1 (fr)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL123563A (en) 1995-09-07 2002-02-10 Smithkline Beecham Corp Pharmaceutical formulations comprising amoxycillin and clavulanate in a weight ratio between 14:1 and 16:1 inclusive
US5759579A (en) * 1996-12-05 1998-06-02 American Home Products Corporation Pharmaceutical suspension systems
DE19706978A1 (de) * 1997-02-21 1998-08-27 Ulrich Dr Posanski Kombinationspräparat für oral applizierbare Antibiotika
US20010016577A1 (en) * 1998-08-24 2001-08-23 Douglas Joseph Dobrozsi Oral mucoadhesive compositions containing gastrointestinal actives
US6878386B1 (en) 1999-04-13 2005-04-12 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising amoxycillin and potassium clavulanate
US7250176B1 (en) 1999-04-13 2007-07-31 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection
US6294199B1 (en) 1999-04-13 2001-09-25 Beecham Pharmaceuticals (Pte) Limited Method of treating a bacterial infection comprising administering amoxycillin
US6756057B2 (en) 2000-10-12 2004-06-29 Beecham Pharmaceuticals (Pte) Limited Amoxicillin and potassium clavulanate dosage form
AU2001292185A1 (en) 2000-10-12 2002-04-22 Beecham Pharmaceuticals (Pte) Limited Formulation containing amoxicillin
WO2007034924A1 (fr) 2005-09-22 2007-03-29 Meiji Seika Kaisha, Ltd. Inhibiteur de la métallo-pénicillinase
TR201000688A2 (tr) * 2010-01-29 2011-08-22 B�Lg�� Mahmut Aktif madde olarak sefaklor ve klavulanik asit içeren efervesan formülasyonlar.
WO2011142731A2 (fr) 2010-05-14 2011-11-17 Mahmut Bilgic Formulations comprenant une céphalosporine et un acide clavulanique de troisième génération
EP2568957A1 (fr) 2010-05-14 2013-03-20 Mahmut Bilgic Composition pharmaceutique comprenant la céfixime et un composé dérivé de l'acide clavulanique
WO2011152808A1 (fr) 2010-06-03 2011-12-08 Mahmut Bilgic Formulation comprenant du cefpodoxime proxétil et de l'acide clavulanique

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3266580D1 (en) * 1981-12-02 1985-10-31 Beecham Group Plc Pharmaceutical formulation comprising beta-lactam antibiotics
GB9007945D0 (en) * 1990-04-07 1990-06-06 Beecham Group Plc Pharmaceutical formulation

Also Published As

Publication number Publication date
WO1993000898A1 (fr) 1993-01-21
EP0593573A1 (fr) 1994-04-27
GB9114950D0 (en) 1991-08-28
JPH06508844A (ja) 1994-10-06

Similar Documents

Publication Publication Date Title
SI0862431T1 (en) Use of a paediatric pharmaceutical formulation comprising amoxycillin and clavulanate
HK1050992A1 (zh) 含有藥物配方的阿莫西林和克拉維酸
AU2230692A (en) Pharmaceutical formulation of a beta-lactam antibiotic and clavulanic acid or a water-soluble salt thereof
AU1282195A (en) Powdery pharmaceutical preparation and method of manufacturing same
AU1913792A (en) Novel derivatives of thiopyranopyrrole and preparation thereof
AU5538098A (en) A slow releasing physiologically active pharmaceutical and method of preparation thereof
AU3777597A (en) Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient
AU5863894A (en) Pharmaceutical formulations comprising clavulanic acid alone or in combination with other beta-lactam antibiotics
AU5814096A (en) Composition comprising amoxycillin and clavulanic acid
AU628664B2 (en) Cephalosporin compound and pharmaceutical composition thereof
AU2229392A (en) Method for the preparation of prolonged-release oral pharmaceutical forms containing active substances having a solubility dependent upon the ph value
AU3471995A (en) Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt
AU2059888A (en) Water-soluble antibiotic composition and water-soluble salts of new cephem compounds
AU3081092A (en) Thiadiazine carboxylic acid amide derivatives, methods of preparing them and drugs containing them
AU3160893A (en) Novel bisphosphonic acid derivatives and their use
AU3363193A (en) Pharmaceutical formulations comprising a clavulanic acid salt and erithromycin derivative
AU3949093A (en) A pharmaceutical formulation
AU4853690A (en) Cephalosporin derivatives and processes for their preparation
AU5154393A (en) Pharmaceutical composition containing an antimicrobial agent and an antibiotic
AU7773094A (en) Derivatives of 1-(2-fluorocyclopropyl)-quinolonecarboxylic acid and 1-(2-fluorocyclopropyl)-naphthyridonecarboxylic acid
NZ228403A (en) Cephalosporin derivatives and pharmaceutical compositions
IL82767A0 (en) Pharmaceutical formulation comprising a cephem and a penem derivative for the treatment of bacterial infections
AU4548289A (en) Penem derivatives and processes for their preparation
AU2794492A (en) 3,4-dihydro-4-oxo-3-(prop-2-enyl)-1-phtalazineacetic acids and derivatives, preparations thereof and drugs containing same
AU625163B2 (en) Dihydrocaffeic acid derivatives and pharmaceutical preparations containing same